Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin, Cisplatin, and 5-FU in Advanced Esophageal Cancer
NCT00259402Phase 2Completed
- Sponsor
- Sanofi
- Start
- Feb 2000
- Primary completion
- Oct 2008
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in esophageal cancer, gastric cancer (GC), sponsored by Sanofi. Started Feb 2000; status: completed.
02
Drugs
oxaliplatin
03
Conditions
esophageal cancergastric cancer (GC)
Beyond the preview
Go deeper on NCT00259402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00259402.